| E-Articles |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Health and Fitness > Obesity > Child Obesity and Depression |
|
E-Articles - Child Obesity and Depression
Child obesity and depression are not alien with each other. In fact the two, more often than not, always go to together. When ther According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product e is child obesity there is a possible presence of depression. When depression is prevalent, most likely obesity is expected to be ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in present too. Child obesity and depression are two of the most debilitating health problems that have affected more children than lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. efore. The number of children suffering from the ill effects of obesity is increasing which is conversely proportional to the ris here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe ing number of children suffering from depression. Though it has not been established that the main cause of depression is obesity d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro ikewise the sole contributing factor of obesity is depression is yet to be proven, but the link between child obesity and depressi ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc on is so clear that its needs immediate attention. Obesity among children can be traumatic. It causes social stigma, which makes easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi children withdrew from socializing with their peers. Children may develop a poor self-image of them and continue to harbor thought nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically of not being liked at all. Because society views obesity as something negative and unwanted, obese children are incapacitated to and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ interact with children their age. They tend to shy away from children’s group activities. Their ability to think creatively is ha ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi pered, thus they become too dependent. They prefer staying at home than spending time with their friends. These scenarios may alre ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a ady be early signs of depression. Any indication of depression among children is alarming, which must be corrected right away. De dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod pression regardless of its cause can also be a cause of obesity. Children suffering from depression stay at home more often. Since cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin they have difficulty relating with other children they prefer to stay at home and watch television instead. They become couch pot tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen ato. They have the tendency to eat more than what is being required of them. If this continues these children will gain weight abo t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel e the ideal weight for their age. Overtime, these children become obese. They have less time engaging in physical activities too, ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust which could aggravate their weight problem. Child obesity and depression seemed to be inseparable. Regardless of which comes fir y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products st obesity and depression should not be taken for granted. Statistics from health organizations show that today more children are . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de uffering from depression and obesity or both. Programs that are geared towards improving the lives of children should be implemen elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip ted. Quality living should not be deprived from them because it is their right too. Child obesity and depression has to be stopped tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Health Insurance & Your Small Business All About DVD Part 2: The Mess With Formats
|